Roswell Biotechnologies, Inc. announced a Molecular Electronics (ME) Platform for biosensing applications. The company kicked off an early development partnership program for the Roswell Molecular Electronics Platform in drug discovery, molecular diagnostics, and sequencing. A peer-review paper, authored by Roswell scientists, and professors George Church, PhD, of Harvard and MIT and James Tour, PhD, of Rice University, is under review at The Proceedings of the National Academy of Sciences.
The ME Platform integrates single molecules into electronic circuits acting as sensor elements creating the first fully scaled biosensors on standard semiconductor chips. The sensor translates the dynamic process of molecular interactions into electrical measurements in real-time. The platform is being developed for applications in drug discovery, molecular diagnostics, and sequencing. A series of whitepapers on the platform and applications may be accessed here.
Original Release: PR Newswire
